Module 3 Weekly Note.

profilenikkyvu
Chapter3slides.pptx

Twelve-transmembrane

region transporter

~ 30% of psychotropic drugs

Seven-transmembrane region

G-protein linked

~ 30% of psychotropic drugs

Enzyme

~ 10% of psychotropic drugs

The Five Molecular Targets of Psychotropic Drugs

Four-transmembrane region

ligand-gated ion channel

~ 20% of psychotropic drugs

Six-transmembrane region

voltage-gated ion channel

~ 10% of psychotropic drugs

2-1

Stahl's Essential Psychopharmacology, 5th edition, 2021, copyright NEI. All rights reserved.

Key ligand-Gated Ion Channels Directly Targeted by Psychotropic Drugs

Neurotransmitter Receptor subtype directly targeted Pharmacological action Therapeutic action
Acetylcholine α4β2-nicotinic receptors Partial agonist Smoking cessation
GABA GABA-A benzodiazepine receptors Full agonist, phasic inhibition Anxiolytic
GABA-A non-benzodiazepine PAM sites Full agonist, phasic inhibition Improves insomnia
GABA-A neurosteroid sites (benzodiazepine insensitive) Full agonist, tonic inhibition Post-partum depression Rapid-acting antidepressant Anesthetic
Glutamate NMDA NAM channels sites/Mg2+ sites Antagonist Procognitive in Alzheimer disease
NMDA open channel sites Antagonist Dissociative hallucinogen Anesthetic Pseudobulbar affect Agitation in Alzheimer disease Rapid-acting antidepressant Treatment-resistant depression
Serotonin 5HT3 Antagonist Procognitive Antidepressant Reduce chemotherapy-induced emesis

Stahl's Essential Psychopharmacology, 5th edition, 2021, copyright NEI. All rights reserved.

Ligand-Gated Ion Channels Have a Gatekeeper

3-1

Stahl's Essential Psychopharmacology, 5th edition, 2021, copyright NEI. All rights reserved.

Pentameric Ligand-Gated Ion Channels

Neurotransmitter Receptor Subtype
Acetylcholine Nicotinic receptors (e.g., α7-nicotinic receptors; α4β2-nicotinic receptors)
GABA GABA-A receptors (e.g., α1 subunits; γ subunits; δ subunits)
Glycine Strychnine-sensitive glycine receptors
Serotonin 5HT3 receptors

4 Transmembrane Regions, 5 Subunits

Stahl's Essential Psychopharmacology, 5th edition, 2021, copyright NEI. All rights reserved.

=

3-2A

Stahl's Essential Psychopharmacology, 5th edition, 2021, copyright NEI. All rights reserved.

=

3-2B

Stahl's Essential Psychopharmacology, 5th edition, 2021, copyright NEI. All rights reserved.

=

3-2C

Stahl's Essential Psychopharmacology, 5th edition, 2021, copyright NEI. All rights reserved.

Tetrameric Ligand-Gated Ion Channels

Neurotransmitter Receptor Subtype
Glutamate AMPA (e.g., GluR1–4 subunits)
KAINATE (e.g., GluR5–7, KA1–2 subunits)
NMDA (e.g., NMDAR1, NMDAR2A–D, NMDAR3A subunits)

3 Transmembrane Regions, 1 Re-entrant Loop, 4 Subunits

Stahl's Essential Psychopharmacology, 5th edition, 2021, copyright NEI. All rights reserved.

=

3-3A

Stahl's Essential Psychopharmacology, 5th edition, 2021, copyright NEI. All rights reserved.

=

3-3B

Stahl's Essential Psychopharmacology, 5th edition, 2021, copyright NEI. All rights reserved.

=

3-3C

Stahl's Essential Psychopharmacology, 5th edition, 2021, copyright NEI. All rights reserved.

The Agonist Spectrum

3-4

Stahl's Essential Psychopharmacology, 5th edition, 2021, copyright NEI. All rights reserved.

agonist

channel in its resting state in the absence

of agonist

agonist binds to the receptor and the

channel is more frequently open

3-5AB

Stahl's Essential Psychopharmacology, 5th edition, 2021, copyright NEI. All rights reserved.

channel in its resting state

antagonist binds to the receptor, not affecting the frequency of opening of the channel compared to the resting

state of no agonist

antagonist

3-6AB

Stahl's Essential Psychopharmacology, 5th edition, 2021, copyright NEI. All rights reserved.

antagonist

the agonist causes the channel to become

open more frequently

agonist

the antagonist takes over and puts the channel back into the resting state

agonist

antagonist

3-7AB

Stahl's Essential Psychopharmacology, 5th edition, 2021, copyright NEI. All rights reserved.

channel in its resting state

partial

agonist

partial agonist binds to the receptor and

causes it to open more frequently than

the resting state but less frequently

than with a full agonist

3-8AB

Stahl's Essential Psychopharmacology, 5th edition, 2021, copyright NEI. All rights reserved.

channel in its resting state

the full agonist opens the channel

maximally and frequently

the partial agonist

causes the

channel to open

more frequently;

in this case the

partial agonist is

having a net

agonist action

the partial agonist

causes the

channel to open

less frequently;

in this case

the partial agonist is

having a net

antagonistic action

3-9

Stahl's Essential Psychopharmacology, 5th edition, 2021, copyright NEI. All rights reserved.

partial

agonist

antagonist

partial agonist binds to the receptor and

causes it to open more frequently than

the resting state but less frequently

than with a full agonist

the antagonist causes the channel

to return to baseline

antagonist

3-10AB

Stahl's Essential Psychopharmacology, 5th edition, 2021, copyright NEI. All rights reserved.

channel in its resting state

inverse agonist

channel closed

the inverse agonist causes the channel to open very infrequently and eventually stabilizes it in an inactive state

channel closed

and inactivated

3-11AB

Stahl's Essential Psychopharmacology, 5th edition, 2021, copyright NEI. All rights reserved.

antagonist

the inverse agonist causes the channel

to stabilize in an inactive form

inverse agonist

the antagonist returns the channel

to the resting state

antagonist

3-12AB

Stahl's Essential Psychopharmacology, 5th edition, 2021, copyright NEI. All rights reserved.

resting state stabilized

by antagonist

resting state

inactivated state possibly reversed

immediately by an antagonist

closed state caused

by inverse agonist

3-13

Stahl's Essential Psychopharmacology, 5th edition, 2021, copyright NEI. All rights reserved.

channel in

resting state

channel open

channel closed

channel desensitized

channel inactivated

3-14

Stahl's Essential Psychopharmacology, 5th edition, 2021, copyright NEI. All rights reserved.

desensitized state

activated by prolonged agonist

open state

activated by acute agonist

resting state

inactivated state

not immediately reversed by

removal of agonist

order of hours

order of hours

3-15

Stahl's Essential Psychopharmacology, 5th edition, 2021, copyright NEI. All rights reserved.

binding site

within

membrane

neurotransmitter

PAM

+

When a neurotransmitter binds to receptors making up an ion channel, the channel

opens more frequently. However, when BOTH the neurotransmitter and a positive allosteric modulator (PAM) are bound to the receptor, the channel opens much more frequently, allowing more ions into the cell.

3-16

Stahl's Essential Psychopharmacology, 5th edition, 2021, copyright NEI. All rights reserved.

neurotransmitter

NAM

-

When a neurotransmitter binds to receptors making up an ion channel, the channel

opens more frequently. However, when BOTH the neurotransmitter and a negative allosteric modulator (NAM) are bound to the receptor, the channel opens much less frequently, allowing fewer ions into the cell.

3-17

Stahl's Essential Psychopharmacology, 5th edition, 2021, copyright NEI. All rights reserved.

Ionic Components of an Action Potential

Na+

Ca++

K+

3-18

Stahl's Essential Psychopharmacology, 5th edition, 2021, copyright NEI. All rights reserved.

voltage-sensitive sodium channel (VSSC)

voltage-sensitive calcium channel (VSCC)

outside the cell

inside the cell

Na+

Ca++

3-19

Stahl's Essential Psychopharmacology, 5th edition, 2021, copyright NEI. All rights reserved.

Four Subunits Combine to Form the Alpha Pore Subunit, or Channel,

for Sodium of a VSSC (Voltage-Sensitive Sodium Channel)

outside the cell

inside the cell

pore inactivation

pore inactivation

outside the cell

inside the cell

outside the cell

inside the cell

pore inactivation

Na+

=

3-20

Stahl's Essential Psychopharmacology, 5th edition, 2021, copyright NEI. All rights reserved.

Three States of a Voltage-Sensitive Sodium Channel (VSSC)

closed and inactivated

inactivated

open

3-21

Stahl's Essential Psychopharmacology, 5th edition, 2021, copyright NEI. All rights reserved.

Four Subunits Combine to Form the Alpha Pore Subunit, or Channel,

for Calcium of a VSCC (Voltage-Sensitive Calcium Channel)

outside the cell

inside the cell

snare

outside the cell

inside the cell

Ca++

=

outside the cell

inside the cell

3-22

Stahl's Essential Psychopharmacology, 5th edition, 2021, copyright NEI. All rights reserved.

Opening a Presynaptic Voltage-Sensitive N or P/Q

Calcium Channel: Triggers Neurotransmitter Release

glutamate

vesicle

snare

Ca++

3-23

Stahl's Essential Psychopharmacology, 5th edition, 2021, copyright NEI. All rights reserved.

Docking of Synaptic Vesicle with Presynaptic Membrane,

VSCC (Voltage-Sensitive Calcium Channel,) and Snare Proteins

3-24

Stahl's Essential Psychopharmacology, 5th edition, 2021, copyright NEI. All rights reserved.

Summary: From Presynaptic to Postsynaptic Signal Propagation

reception

integration

chemical encoding

electrical encoding

signal propagation

presynaptic signal transduction

postsynaptic signal transduction

reception

integration

chemical encoding

signal propagation

signal propagation

presynaptic signal transduction

3-25

Stahl's Essential Psychopharmacology, 5th edition, 2021, copyright NEI. All rights reserved.

VSSC

VSCC

neurotransmitter

vesicle

Na++

action potential

3-26

Stahl's Essential Psychopharmacology, 5th edition, 2021, copyright NEI. All rights reserved.

VSSC

Ca++

VSCC

3-26

Stahl's Essential Psychopharmacology, 5th edition, 2021, copyright NEI. All rights reserved.

Subtypes of Voltage-Sensitive Calcium Channels (VSCCs)

Type Pore-forming subunit Location Function
L Cav 1.2, 1.3 Cell bodies, dendrites Gene expression, synaptic integration
N Cav 2.2 Nerve terminals Dendrites, cell bodies Transmitter release Synaptic integration
P/Q Cav 2.1 Nerve terminals Dendrites, cell bodies Transmitter release Synaptic integration
R Cav 2.3 Nerve terminals Cell bodies, dendrites Transmitter release Repetitive firing, synaptic integration
T Cav 3.1, 3.2, 3.3 Cell bodies, dendrites Pacemaking, repetitive firing, synaptic integration

Stahl's Essential Psychopharmacology, 5th edition, 2021, copyright NEI. All rights reserved.

image1.png

image2.png

image3.png

image4.png

image5.png

image6.png

image7.png

image8.png

image9.png

image10.png

image11.png

image12.png

image13.png

image14.png

image15.png

image16.png

image17.png

image18.png

image19.png

image20.png

image29.png

image21.png

image22.png

image23.png

image24.png

image25.png

image26.png

image27.png

image28.png

image30.png

image31.png

image32.png

image33.png

image34.png

image35.png

image36.png

image37.png

image38.png

image39.png

image40.png

image41.png

image42.png

image43.png

image44.png

image45.png

image46.png

image47.png

image48.png

image49.png

image50.png

image51.png

image52.png

image53.png

image54.png

image55.png

image56.png

image57.png

image58.png

image59.png

image60.png

image61.png

image62.png

image63.png

image64.png

image65.png

image66.png

image67.png

image68.png

image69.png

image70.png

image71.png

image72.png

image73.png

image74.png

image75.png

image76.png

image77.png

image78.png

image79.png

image80.png

image81.png

image82.png

image83.png

image84.png

image85.png

image86.png

image87.png

image88.png

image89.png

image90.png

image91.png

image92.png

image93.png

image94.png

image95.png

image96.png

image97.png

image98.png

image99.png

image100.png

image101.png

image102.png

image103.png

image104.png

image105.png

image106.png

image107.png

image108.png

image109.png

image110.png

image111.png

image112.png

image113.png

image114.png

image115.png

image116.png

image117.png

image118.png

image119.png

image125.png

image120.png

image121.png

image122.png

image123.png

image124.png